Zobrazeno 1 - 10
of 30
pro vyhledávání: '"Robert Lehr"'
Autor:
Robert Lehr, Fumiko Futamura
Publikováno v:
Mathematics Magazine. 90:267-277
We take a fresh perspective on an old idea and create an alternate way to answer the question: where should we stand in front of an image in two-point perspective to view it correctly? We review kn...
Autor:
Jean-Pierre Bronowicki, Seung Kew Yoon, Arun J. Sanyal, Jean Francois H. Geschwind, Lucy Dagher, K. Nakajima, Jorge A. Marrero, Robert Lehr, Sheng Long Ye, Masatoshi Kudo, Riccardo Lencioni, Junji Furuse, Alan P. Venook, Tadatoshi Takayama, Xiaoping Chen, Stephanie Heldner, Laura Ladrón de Guevara, Christos Papandreou
Publikováno v:
Radiology
Radiology, Radiological Society of North America, 2016, 279 (2), pp.630-640. ⟨10.1148/radiol.2015150667⟩
Radiology, Radiological Society of North America, 2016, 279 (2), pp.630-640. ⟨10.1148/radiol.2015150667⟩
International audience; Purpose: To evaluate transarterial chemoembolization (TACE) use prior to and concomitantly with sorafenib in patients with unresectable hepatocellular carcinoma (HCC) across different global regions.Materials and Methods: GIDE
Autor:
Robert Lehr, Jean-Pierre Bronowicki, Seung Kew Yoon, Masatoshi Kudo, Lázaro Guevara, K. Nakajima, Tadatoshi Takayama, Sheng-Long Ye, Stephanie Heldner, Xiaoping Chen, Arun J. Sanyal, Lucy Dagher, Junji Furuse, Riccardo Lencioni, J. F. Geschwind, Christos N. Papandreou
Publikováno v:
International Journal of Clinical Practice
International Journal of Clinical Practice, Wiley, 2014, 68 (5), pp.609-617. ⟨10.1111/ijcp.12352⟩
International Journal of Clinical Practice, Wiley, 2014, 68 (5), pp.609-617. ⟨10.1111/ijcp.12352⟩
International audience; BackgroundGIDEON (Global Investigation of therapeutic DEcisions in hepatocellular carcinoma [HCC] and Of its treatment with sorafeNib) is a global, prospective, non-interventional study undertaken to evaluate the safety of sor
Publikováno v:
Journal of Magnetic Resonance Imaging. 39:410-418
Purpose To investigate the efficacy and safety of three doses of gadobutrol and determine the minimum effective dose for contrast-enhanced MRI of the central nervous system (CNS). Materials and Methods This was a Phase II, multicenter, double-blind,
Autor:
K. Nakajima, Alan P. Venook, Jean Francois H. Geschwind, Arun J. Sanyal, Seung Kew Yoon, Lucy Dagher, Christos Papandreou, Xiaoping Chen, Laura Ladrón de Guevara, Jorge A. Marrero, Tadatoshi Takayama, Stephanie Heldner, Junji Furuse, Riccardo Lencioni, Masatoshi Kudo, Jean-Pierre Bronowicki, Robert Lehr, Sheng Long Ye
Publikováno v:
Liver International
Liver International, Wiley-Blackwell, 2016, 36 (8), pp.1196-1205. ⟨10.1111/liv.13096⟩
Liver International, Wiley-Blackwell, 2016, 36 (8), pp.1196-1205. ⟨10.1111/liv.13096⟩
International audience; Background & AimsTreatment approaches for hepatocellular carcinoma (HCC) vary across countries, but these differences and their potential impact on outcomes have not been comprehensively assessed. Data from the multinational G
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f5a786c25f6a8065afe385686f14e627
http://hdl.handle.net/11568/902275
http://hdl.handle.net/11568/902275
Autor:
Robert Lehr, Franciska K. Kashanian
Publikováno v:
Drug Information Journal. 43:525-532
A clinical trial of the efficacy of a contrast agent used with a diagnostic procedure may present design and analysis issues that need to be considered and managed. Choice of primary variable and summary measures, multiple evaluations on each patient
Autor:
Arun J. Sanyal, Lucy Dagher, Alan P. Venook, Seung Kew Yoon, Robert Lehr, Sheng Long Ye, Laura Ladrón de Guevara, Xiaoping Chen, Tadatoshi Takayama, Riccardo Lencioni, Jean Francois H. Geschwind, Stephanie Heldner, Christos Papandreou, K. Nakajima, Junji Furuse, Masatoshi Kudo, Jean-Pierre Bronowicki, Jorge A. Marrero
Publikováno v:
Journal of hepatology. 65(6)
Background & Aims GIDEON (Global Investigation of therapeutic DEcisions in hepatocellular carcinoma and Of its treatment with sorafeNib) is a prospective, observational registry study evaluating the safety of sorafenib and treatment practices in hepa
Autor:
Robert Lehr
Publikováno v:
Drug Information Journal. 35:1227-1233
Although McNemar’s test for correlated proportions is easy to apply and interpret, planning studies based on this test with clinicians is not trivial. Trials that involve two measurements made on the same or matched subjects under different treatme